Personalized predictions study for a 53 year old woman who takes Divalproex, Risperidone - from FDA reports


We analyzed 2,002,167 related reports to generate the predictions. There are 2 types of predictions: symptoms and conditions with supporting statistic provided. You can discuss the predictions with your healthcare provider.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.

2,002,167 related reports were analyzed:

Most common symptoms:

Acute psychosis
  • 100.0% for females aged 53 (±5) who take divalproex|risperidone and have acute psychosis
Atrial fibrillation/flutter
  • 10.96% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Cardiac arrest
  • 19.18% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Constipation
  • 8.22% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Depression
  • 5.81% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
Dizziness
  • 5.18% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
Drowsiness
  • 8.22% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Drug ineffective
  • 6.85% for females aged 53 (±5) who have schizoaffective disorder bipolar type
  • 5.35% for females aged 53 (±5) who take divalproex
  • 5.35% for females aged 53 (±5) who take risperidone
Dyspnea
  • 8.22% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Electrocardiogram qt prolonged
  • 20.55% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Fall
  • 8.22% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Fatigue
  • 5.81% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
  • 5.69% for females aged 53 (±5) who take divalproex
  • 5.69% for females aged 53 (±5) who take risperidone
Fever
  • 8.22% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Headache
  • 5.2% for females aged 53 (±5) who take divalproex
  • 5.2% for females aged 53 (±5) who take risperidone
Hypotension
  • 8.22% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Insomnia
  • 5.14% for females aged 53 (±5) who have bipolar ii disorder
Loss of consciousness
  • 12.33% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Mania
  • 6.85% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Memory loss
  • 5.49% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
Metabolic disorder
  • 13.7% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Myocarditis
  • 9.59% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Nausea
  • 6.44% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
  • 6.43% for females aged 53 (±5) who take divalproex
  • 6.43% for females aged 53 (±5) who take risperidone
Pneumonia aspiration
  • 21.92% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Psychotic disorder
  • 9.59% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Salivary hypersecretion
  • 12.33% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Sedation
  • 12.33% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Sepsis
  • 20.55% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Stress and anxiety
  • 6.28% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
Torsade de pointes
  • 20.55% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Weight increased
  • 7.06% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type

Most common co-existing conditions:

Aggression
  • 6.85% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Attention deficit hyperactivity disorder
  • 6.12% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
Bipolar ii disorder
  • 88.54% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
Gastroesophageal reflux disease
  • 7.06% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
Generalized anxiety disorder
  • 5.65% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
High blood cholesterol
  • 5.65% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
High blood pressure
  • 7.06% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
Hypothyroidism
  • 7.06% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
  • 5.03% for females aged 53 (±5) who take divalproex|risperidone and have acute psychosis
Insomnia
  • 5.34% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
Multiple sclerosis
  • 9.63% for females aged 53 (±5) who take divalproex
  • 9.63% for females aged 53 (±5) who take risperidone
Rheumatoid arthritis
  • 10.44% for females aged 53 (±5) who take divalproex
  • 10.44% for females aged 53 (±5) who take risperidone
Schizoaffective disorder
  • 9.59% for females aged 53 (±5) who have schizoaffective disorder bipolar type
Schizoaffective disorder bipolar type
  • 11.46% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type
Stress and anxiety
  • 9.89% for females aged 53 (±5) who have bipolar ii disorder|schizoaffective disorder bipolar type

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!